share_log

Shuttle Pharmaceuticals | 8-K: Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma

Shuttle Pharmaceuticals | 8-K:Shuttle Pharmicals向美国食品药品管理局提交针对胶质母细胞瘤患者罗吡多尿苷II期临床试验IND申请

SEC announcement ·  2023/12/11 09:00
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息